ASX-LISTED Medlab Clinical
has cited results of a recent
investigation involving a multistrain
probiotic preparation in a
mice model of High Fat Diet (HFD)/
obesity induced liver steatosis.
“The results convincingly
demonstrated a reduction in
the progression of HFD induced
steatosis,” the company said.The above article was sent to subscribers in Pharmacy Daily's issue from 09 Oct 15 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 09 Oct 15
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.